Subchronic toxicology of diethystilbestrol in the mouse.
This study evaluated the subchronic (14-day) toxicity of selected (0.2, 1.0, and 4.0 mg/kg) daily subcutaneous injections of diethylstilbestrol (DES) in female (C57B1/6 X C3H)F1 mice. Parameters observed included body and organ weights, gross organ morphology, histopathology, clinical chemistry, and hepatic microsomal enzyme activities. The liver, bone marrow, and thymus are major target organs for DES. Liver enlargement, with associated histopathological changes consistent with mild hepatitis, centrolobular necrosis, and sinusoidal changes were observed. Supporting the histological changes were alterations in serum enzyme levels and microsomal enzyme activity. Bone marrow changes included decreases in the number of cells as well as the number of colony forming units per gram stem cells. Toxicity to the thymus was evidenced by decreased thymic weights and lymphocyte depletion. The hepatic and thymic effects were observed at the lowest (0.2 mg/kg) dose. Although all parameters were not assessed for recovery, those that were evaluated returned to control levels by thirty days after treatment.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001854:Bone Marrow Cells; D001921:Brain / Q000187:drug effects; D004054:Diethylstilbestrol / Q000633:toxicity*; D004573:Electrolytes / Q000097:blood; D004798:Enzymes / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006529:Hepatomegaly / Q000139:chemically induced; D007958:Leukocyte Count; D051379:Mice; D008862:Microsomes, Liver / Q000378:metabolism; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D011516:Prothrombin / Q000378:metabolism
D004573:Electrolytes; D004798:Enzymes; D004054:Diethylstilbestrol; D011516:Prothrombin; D005340:Fibrinogen; D006899:Mixed Function Oxygenases